Cite
Kreiter S, Vormehr M, van de Roemer N, et al. Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015;523(7560):370doi: 10.1038/nature14567.
Kreiter, S., Vormehr, M., van de Roemer, N., Diken, M., Löwer, M., Diekmann, J., Boegel, S., Schrörs, B., Vascotto, F., Castle, J. C., Tadmor, A. D., Schoenberger, S. P., Huber, C., Türeci, �. �., & Sahin, U. (2015). Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature, 523(7560), 370. https://doi.org/10.1038/nature14567
Kreiter, Sebastian, et al. "Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer." Nature vol. 523,7560 (2015): 370. doi: https://doi.org/10.1038/nature14567
Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, Boegel S, Schrörs B, Vascotto F, Castle JC, Tadmor AD, Schoenberger SP, Huber C, Türeci Ö, Sahin U. Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015 Jul 16;523(7560):370. doi: 10.1038/nature14567. Epub 2015 Jun 03. PMID: 26040715.
Copy
Download .nbib
